![Pamela Wapnick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pamela Wapnick
Directeur Financier/CFO chez
METAGENOMI THERAPEUTICS, INC.
Fortune : 283 548 $ au 31/05/2026
Profil
Pamela Wapnick is currently Chief Financial Officer at Metagenomi Therapeutics, Inc. since 2023.
Former roles include Chief Financial Officer at Diality, Inc. from 2022 to 2023, Chief Financial Officer at Capsida Biotherapeutics, Inc. from 2019 to 2022, Chief Financial Officer at Graybug Vision, Inc. from 2017 to 2019, Vice President-Finance at Amgen, Inc. in 2016, and Chief Financial Officer positions at True North Therapeutics, Inc. and Metagenomi Technologies LLC.
Education includes undergraduate studies at Wellesley College and an MBA from Columbia Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/06/2026 | 208 491 ( 0,55 % ) | 283 548 $ | 31/05/2026 |
Postes actifs de Pamela Wapnick
| Sociétés | Poste | Début |
|---|---|---|
| METAGENOMI THERAPEUTICS, INC. | Directeur Financier/CFO | 01/09/2023 |
Anciens postes connus de Pamela Wapnick
| Sociétés | Poste | Fin |
|---|---|---|
Diality, Inc.
 Diality, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Directeur Financier/CFO | 01/09/2023 |
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Directeur Financier/CFO | 01/06/2022 |
| CALCIMEDICA, INC. | Directeur Financier/CFO | 01/10/2019 |
| AMGEN INC. | Directeur Financier/CFO | 01/03/2016 |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Directeur Financier/CFO | - |
Formation de Pamela Wapnick
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, which focuses on developing transformative medicines for the treatment of chronic diseases of retina and optic nerve | Health Technology |
Wellesley College
 Wellesley College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Health Technology |
Metagenomi Technologies LLC
 Metagenomi Technologies LLC BiotechnologyHealth Technology Develops genetic medicines using metagenomics-powered genome editing toolbox | Health Technology |
Diality, Inc.
Diality, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
Metagenomi, Inc.
 Metagenomi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a genetic medicines company that develops curative therapeutics for patients | Health Technology |
Choisissez Zonebourse 
